Skip to main content

Table 2 Change in vitamin/mineral supplement daily dose from diagnosis to 6 months a

From: Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study

  

Initiatorsb

Discontinuersc

Continuous users

 

IOM reference intakesd

Change in dose from diagnosis to 6 months

P-valuee

Change in dose from diagnosis to 6 months

P-valuef

Dose at diagnosis

Dose at 6 months

Change from diagnosisg

Multivitamins (pills)

n/a

1.45

0.53

−1.32

0.34

1.39

1.23

−0.17

Vitamin C (mg)

75 mg

615.95

0.01

−557.97

<.0001

780.10

740.57

−26.07

Calcium (mg)

1200 mg

859.31

<.0001

−743.69

0.56

704.55

815.69

119.70

Vitamin E (IU)

15 mcgh

280.89

<.0001

−391.09

0.66

400.97

357.97

−41.32

Vitamin D (IU)

600 mcgg

1064.94

<.0001

−2505.33

0.26

1800.20

2306.79

609.09

Iron (mg)

8 mg

184.13

0.56

−80.08

0.38

129.99

79.66

−73.85

Vitamin B12 (mcg)

2.4 mcg

245.80

<.0001

−612.35

0.18

794.29

625.99

−126.84

Folic acid (folate) (mcg)

400 mcg

416.38

<.0001

−475.81

0.05

616.75

552.73

−42.47

Magnesium (mg)

320 mg

289.02

0.91

−315.55

0.62

293.46

319.25

57.69

Zinc (mg)

8 mg

12.79

<.0001

−17.56

0.004

42.14

38.08

4.46

Vitamin B6 (mg)

1.3-1.5 mg

63.77

0.07

−110.61

0.56

88.96

91.34

−16.14

Vitamin A (IU)

700 mcgi,h

5966.11

0.02

−11113.52

0.93

10736.26

7283.16

−3425.60

Chromium (mg)

0.02 mg

165.46

0.03

−176.16

0.09

280.96

284.16

13.65

Niacin (B3) (mg)

14 mg

167.02

<.0001

−368.21

0.02

850.00

915.86

94.52

Beta carotene (IU)

 

12552.93

0.10

−12750.00

0.15

19722.22

13437.50

−4166.67

Selenium (mcg)

55 mg

101.96

0.11

−111.01

0.21

144.25

137.41

−1.28

Thiamin (B1) (mg)

1.1 mg

57.81

0.07

−28.35

0.17

164.06

179.76

57.14

  1. aOrdered by prevalence of use prior to diagnosis.
  2. bInitiators defined as those taking supplements at six-month follow-up but not at baseline visit.
  3. cDiscontinuers defined as those taking supplements at baseline but not at six-month follow-up visit.
  4. dBased on Institute of Medicine Recommended Dietary Allowances and Adequate Intakes for females age 51 years and older.
  5. eT-test comparing 6 months dose to baseline dose of Continuous Users.
  6. fT-test comparing diagnosis dose to diagnosis dose of Continuous Users.
  7. gThe amount of change may not reflect the apparent difference between diagnosis and 6 months since both measures are required in order to be included.
  8. hIOM recommended dietary allowances for vitamins A, D, and E are expressed in micrograms, while the study values are international units (I.U.).
  9. iThe IOM recommended dietary allowance of 700 mcg vitamin A is expressed in retinol activity equivalents (RAE), where 1 RAE = 1 mcg retinol or 12 mcg beta-carotene.